2008

Conversion Therapy to Everolimus in Renal Transplant Recipients: Results After One Year

Background Two new diagnoses have been causing graft loss during long-term followup, namely, chronic nephropathy and anticalcineurinic toxicity. The advent of the mammalian target of rapamycin (m-TOR) obviates anticalcineurine toxicity and reduces posttransplant malignancy incidence with good inmunosuppressive potential. We examinated the renal and metabolic behavior in renal transplant recipients who required conversion from an […]

Conversion Therapy to Everolimus in Renal Transplant Recipients: Results After One Year Read More »

Experience With Alemtuzumab (Campath-1H) as Induction Agent in Renal Transplantation Followed by Steroid-Free Immunosuppression

Background The purpose of this study was to describe the initial experience with alemtuzumab as induction followed by steroid-free immunosuppression in kidney transplantation. Methods One hundred patients who received renal transplants from living and deceased donors were followed for a median period of 12 months (range  1 to 12). A 30-mg intravenous dose of

Experience With Alemtuzumab (Campath-1H) as Induction Agent in Renal Transplantation Followed by Steroid-Free Immunosuppression Read More »

Use of Nonabsorbable Polymer Ligaclip in Hand-Assisted Laparoscopic Nephrectomy for Living Donor

Background Laparoscopic living donor nephrectomy for kidney transplantation is a technique that began in South America only recently. This procedure offers several advantages compared with open nephrectomy due to the minor pain, better cosmetic results, and shorter length of hospital stay. Herein we have described our experience with the use of nonabsorbable polymer ligaclip (NPL)

Use of Nonabsorbable Polymer Ligaclip in Hand-Assisted Laparoscopic Nephrectomy for Living Donor Read More »